| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 11 | 2020 | 427 | 3.600 |
Why?
|
| Tumor Microenvironment | 12 | 2020 | 565 | 3.000 |
Why?
|
| Breast Neoplasms | 27 | 2020 | 2518 | 2.490 |
Why?
|
| Neoplasm Metastasis | 22 | 2020 | 702 | 2.440 |
Why?
|
| RNA Splicing | 10 | 2021 | 227 | 1.430 |
Why?
|
| Neoplasms | 8 | 2020 | 2803 | 1.360 |
Why?
|
| Myeloid-Derived Suppressor Cells | 5 | 2020 | 49 | 1.360 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2020 | 545 | 1.340 |
Why?
|
| Stem Cell Niche | 3 | 2020 | 55 | 1.330 |
Why?
|
| Epithelial-Mesenchymal Transition | 6 | 2019 | 216 | 1.240 |
Why?
|
| Triple Negative Breast Neoplasms | 6 | 2021 | 234 | 1.120 |
Why?
|
| Benzamides | 2 | 2018 | 109 | 1.120 |
Why?
|
| Exons | 10 | 2009 | 800 | 1.050 |
Why?
|
| Osteogenesis | 2 | 2018 | 154 | 0.990 |
Why?
|
| Pyrazoles | 2 | 2018 | 305 | 0.960 |
Why?
|
| Macrophages | 5 | 2020 | 627 | 0.960 |
Why?
|
| RNA Splice Sites | 7 | 2009 | 89 | 0.950 |
Why?
|
| Neutrophils | 3 | 2020 | 381 | 0.870 |
Why?
|
| Myeloid Cells | 3 | 2019 | 102 | 0.780 |
Why?
|
| Bone Marrow | 4 | 2017 | 325 | 0.770 |
Why?
|
| Cell Line, Tumor | 23 | 2021 | 3396 | 0.720 |
Why?
|
| Tropism | 1 | 2020 | 9 | 0.710 |
Why?
|
| Methylmalonic Acid | 1 | 2020 | 15 | 0.700 |
Why?
|
| Animals | 48 | 2021 | 34349 | 0.680 |
Why?
|
| Transforming Growth Factor beta | 5 | 2015 | 465 | 0.630 |
Why?
|
| Iliac Artery | 2 | 2016 | 92 | 0.630 |
Why?
|
| Introns | 7 | 2021 | 300 | 0.630 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 3 | 2009 | 16 | 0.610 |
Why?
|
| Neovascularization, Physiologic | 2 | 2017 | 215 | 0.610 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 1705 | 0.600 |
Why?
|
| Bone and Bones | 2 | 2017 | 267 | 0.590 |
Why?
|
| Signal Transduction | 17 | 2021 | 4585 | 0.580 |
Why?
|
| Aurora Kinases | 1 | 2017 | 32 | 0.550 |
Why?
|
| Immunotherapy | 2 | 2019 | 680 | 0.550 |
Why?
|
| RNA Precursors | 4 | 2015 | 67 | 0.530 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 432 | 0.520 |
Why?
|
| Mice | 34 | 2021 | 17727 | 0.520 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 264 | 0.500 |
Why?
|
| Disease Progression | 8 | 2020 | 2089 | 0.500 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 241 | 0.500 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 733 | 0.490 |
Why?
|
| Cell Separation | 1 | 2015 | 230 | 0.470 |
Why?
|
| Interleukin-17 | 1 | 2015 | 120 | 0.470 |
Why?
|
| Humans | 62 | 2021 | 125667 | 0.470 |
Why?
|
| Specimen Handling | 1 | 2015 | 142 | 0.470 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2016 | 630 | 0.450 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2013 | 284 | 0.450 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 472 | 0.440 |
Why?
|
| Mice, Nude | 8 | 2020 | 717 | 0.420 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 691 | 0.390 |
Why?
|
| Alternative Splicing | 4 | 2008 | 354 | 0.380 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 1962 | 0.370 |
Why?
|
| Mice, Inbred BALB C | 4 | 2018 | 1000 | 0.370 |
Why?
|
| Receptors, Estrogen | 2 | 2018 | 794 | 0.360 |
Why?
|
| Female | 36 | 2021 | 66998 | 0.350 |
Why?
|
| Brain Neoplasms | 5 | 2021 | 1297 | 0.330 |
Why?
|
| Computational Biology | 2 | 2005 | 816 | 0.330 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2009 | 6 | 0.330 |
Why?
|
| Disease Models, Animal | 8 | 2019 | 4409 | 0.320 |
Why?
|
| Lung Neoplasms | 9 | 2020 | 1659 | 0.320 |
Why?
|
| ErbB Receptors | 4 | 2020 | 284 | 0.310 |
Why?
|
| MCF-7 Cells | 3 | 2020 | 222 | 0.310 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2020 | 908 | 0.300 |
Why?
|
| RNA, Messenger | 5 | 2018 | 2824 | 0.300 |
Why?
|
| Spliceosomes | 2 | 2021 | 54 | 0.290 |
Why?
|
| Neoplastic Cells, Circulating | 3 | 2015 | 74 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 4416 | 0.280 |
Why?
|
| Cell Movement | 4 | 2018 | 855 | 0.270 |
Why?
|
| Estrogen Receptor alpha | 2 | 2020 | 458 | 0.270 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2018 | 66 | 0.260 |
Why?
|
| Evolution, Molecular | 2 | 2008 | 668 | 0.260 |
Why?
|
| Vertebrates | 1 | 2006 | 41 | 0.260 |
Why?
|
| Cell Survival | 5 | 2021 | 819 | 0.260 |
Why?
|
| Models, Genetic | 3 | 2017 | 761 | 0.260 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2020 | 543 | 0.230 |
Why?
|
| Wnt Signaling Pathway | 2 | 2018 | 193 | 0.230 |
Why?
|
| Receptor, ErbB-2 | 3 | 2018 | 516 | 0.230 |
Why?
|
| Codon, Terminator | 1 | 2004 | 26 | 0.220 |
Why?
|
| Artificial Intelligence | 2 | 2005 | 244 | 0.220 |
Why?
|
| Genome | 1 | 2006 | 475 | 0.210 |
Why?
|
| Cell Proliferation | 6 | 2020 | 2356 | 0.210 |
Why?
|
| 5' Untranslated Regions | 2 | 2018 | 58 | 0.200 |
Why?
|
| Codon, Nonsense | 1 | 2003 | 131 | 0.200 |
Why?
|
| Tamoxifen | 2 | 2020 | 363 | 0.190 |
Why?
|
| Fibroblasts | 2 | 2019 | 889 | 0.190 |
Why?
|
| Statistics as Topic | 2 | 2017 | 257 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2018 | 492 | 0.190 |
Why?
|
| Chemokine CXCL12 | 2 | 2013 | 37 | 0.190 |
Why?
|
| Transcription, Genetic | 4 | 2014 | 1705 | 0.190 |
Why?
|
| Neoplasm Staging | 2 | 2015 | 1278 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 2008 | 2526 | 0.180 |
Why?
|
| Neoplasm Transplantation | 4 | 2021 | 383 | 0.180 |
Why?
|
| Calcium | 3 | 2018 | 1103 | 0.180 |
Why?
|
| Sirtuin 3 | 1 | 2020 | 9 | 0.180 |
Why?
|
| Receptors, Androgen | 2 | 2020 | 414 | 0.180 |
Why?
|
| Aconitate Hydratase | 1 | 2020 | 11 | 0.180 |
Why?
|
| DNA Fingerprinting | 1 | 2021 | 107 | 0.180 |
Why?
|
| Mice, SCID | 6 | 2021 | 583 | 0.180 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2020 | 31 | 0.170 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 22 | 0.170 |
Why?
|
| Cadherins | 3 | 2018 | 172 | 0.170 |
Why?
|
| Osteoclasts | 1 | 2020 | 55 | 0.170 |
Why?
|
| Carcinoma | 2 | 2020 | 290 | 0.170 |
Why?
|
| RNA Interference | 3 | 2018 | 507 | 0.170 |
Why?
|
| Neurofibromin 1 | 1 | 2020 | 42 | 0.160 |
Why?
|
| Transcription Factors | 3 | 2020 | 2604 | 0.160 |
Why?
|
| Immunity | 1 | 2021 | 192 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2015 | 1160 | 0.160 |
Why?
|
| Uridine Diphosphate Glucose Dehydrogenase | 1 | 2019 | 5 | 0.160 |
Why?
|
| Prostatic Neoplasms | 2 | 2020 | 1549 | 0.160 |
Why?
|
| Granulocytes | 1 | 2019 | 65 | 0.160 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2020 | 348 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 217 | 0.160 |
Why?
|
| U937 Cells | 1 | 2018 | 25 | 0.150 |
Why?
|
| Connexin 43 | 1 | 2018 | 29 | 0.150 |
Why?
|
| RAW 264.7 Cells | 1 | 2018 | 40 | 0.150 |
Why?
|
| 3T3 Cells | 1 | 2018 | 120 | 0.150 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2005 | 299 | 0.150 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 3896 | 0.150 |
Why?
|
| Everolimus | 1 | 2018 | 50 | 0.150 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 96 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2017 | 246 | 0.150 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2018 | 10 | 0.150 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 24 | 0.150 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2018 | 129 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 357 | 0.140 |
Why?
|
| Genomics | 3 | 2021 | 1516 | 0.140 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 357 | 0.140 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 558 | 0.140 |
Why?
|
| Crosses, Genetic | 1 | 2017 | 163 | 0.140 |
Why?
|
| Nuclear Proteins | 3 | 2015 | 1273 | 0.140 |
Why?
|
| Transplantation, Heterologous | 3 | 2013 | 260 | 0.140 |
Why?
|
| Wnt Proteins | 3 | 2013 | 211 | 0.140 |
Why?
|
| Pericytes | 1 | 2017 | 21 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 1 | 2019 | 623 | 0.140 |
Why?
|
| Cell Hypoxia | 1 | 2017 | 95 | 0.140 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 69 | 0.140 |
Why?
|
| Biphenyl Compounds | 1 | 2017 | 62 | 0.140 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2017 | 38 | 0.130 |
Why?
|
| Morpholines | 1 | 2017 | 58 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2017 | 76 | 0.130 |
Why?
|
| Calcium Signaling | 1 | 2018 | 244 | 0.130 |
Why?
|
| MicroRNAs | 2 | 2016 | 851 | 0.130 |
Why?
|
| Stromal Cells | 2 | 2015 | 302 | 0.130 |
Why?
|
| Up-Regulation | 2 | 2018 | 871 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3753 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 98 | 0.130 |
Why?
|
| Hindlimb | 1 | 2016 | 80 | 0.130 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 120 | 0.130 |
Why?
|
| Base Sequence | 4 | 2021 | 3108 | 0.130 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 271 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 557 | 0.130 |
Why?
|
| Th1 Cells | 1 | 2017 | 153 | 0.130 |
Why?
|
| Genetic Heterogeneity | 1 | 2016 | 127 | 0.130 |
Why?
|
| Pyridones | 1 | 2017 | 119 | 0.130 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 487 | 0.130 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 65 | 0.130 |
Why?
|
| Injections, Intra-Arterial | 1 | 2015 | 17 | 0.130 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2015 | 15 | 0.130 |
Why?
|
| Recombination, Genetic | 1 | 2017 | 448 | 0.130 |
Why?
|
| Adoptive Transfer | 1 | 2017 | 236 | 0.120 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 96 | 0.120 |
Why?
|
| Mitochondria | 1 | 2020 | 680 | 0.120 |
Why?
|
| Tenascin | 2 | 2015 | 31 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 318 | 0.120 |
Why?
|
| Femur | 1 | 2015 | 67 | 0.120 |
Why?
|
| Smad Proteins | 2 | 2015 | 43 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2016 | 85 | 0.120 |
Why?
|
| Tumor Escape | 1 | 2015 | 63 | 0.120 |
Why?
|
| Tibia | 1 | 2015 | 70 | 0.120 |
Why?
|
| Genes, myc | 1 | 2015 | 102 | 0.120 |
Why?
|
| Endothelial Cells | 2 | 2017 | 527 | 0.120 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 663 | 0.120 |
Why?
|
| Interferon-gamma | 1 | 2017 | 505 | 0.120 |
Why?
|
| 14-3-3 Proteins | 1 | 2015 | 54 | 0.120 |
Why?
|
| Prognosis | 4 | 2018 | 4690 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 260 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 147 | 0.110 |
Why?
|
| Plasminogen Activator Inhibitor 2 | 1 | 2014 | 1 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 209 | 0.110 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 112 | 0.110 |
Why?
|
| Fibrinolysin | 1 | 2014 | 12 | 0.110 |
Why?
|
| Models, Biological | 2 | 2017 | 1468 | 0.110 |
Why?
|
| Serpins | 1 | 2014 | 27 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 131 | 0.110 |
Why?
|
| Carcinogenesis | 2 | 2014 | 340 | 0.110 |
Why?
|
| Prostate | 1 | 2016 | 436 | 0.110 |
Why?
|
| Glucose | 1 | 2018 | 878 | 0.110 |
Why?
|
| Mutation | 5 | 2020 | 5893 | 0.110 |
Why?
|
| Aging | 1 | 2020 | 1182 | 0.110 |
Why?
|
| Neuropeptides | 1 | 2014 | 114 | 0.100 |
Why?
|
| src-Family Kinases | 1 | 2013 | 91 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1526 | 0.100 |
Why?
|
| Gene Expression | 1 | 2017 | 1561 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1727 | 0.100 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2013 | 127 | 0.100 |
Why?
|
| Disease-Free Survival | 2 | 2016 | 907 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 340 | 0.090 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 76 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2011 | 121 | 0.090 |
Why?
|
| Apoptosis | 4 | 2021 | 1810 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 164 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2015 | 740 | 0.090 |
Why?
|
| Mammary Glands, Animal | 1 | 2013 | 478 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2021 | 460 | 0.080 |
Why?
|
| Homeodomain Proteins | 2 | 2011 | 555 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2014 | 817 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2015 | 1751 | 0.080 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 23 | 0.080 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2009 | 12 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6607 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 56 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2018 | 1639 | 0.080 |
Why?
|
| Cricetulus | 1 | 2009 | 101 | 0.080 |
Why?
|
| Genetic Techniques | 2 | 2008 | 107 | 0.080 |
Why?
|
| Sequence Alignment | 2 | 2011 | 620 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 3 | 2020 | 1072 | 0.080 |
Why?
|
| Cricetinae | 1 | 2009 | 422 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2017 | 653 | 0.070 |
Why?
|
| Histones | 1 | 2011 | 536 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 4 | 2015 | 1337 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2018 | 299 | 0.070 |
Why?
|
| Keratinocytes | 1 | 2007 | 62 | 0.070 |
Why?
|
| Gene Amplification | 2 | 2021 | 234 | 0.070 |
Why?
|
| Pyrimidines | 2 | 2015 | 375 | 0.070 |
Why?
|
| Selection, Genetic | 1 | 2008 | 155 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2021 | 201 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 578 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 363 | 0.070 |
Why?
|
| Expressed Sequence Tags | 1 | 2006 | 79 | 0.070 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 37 | 0.070 |
Why?
|
| Alu Elements | 1 | 2006 | 65 | 0.060 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 1026 | 0.060 |
Why?
|
| DNA Helicases | 1 | 2007 | 235 | 0.060 |
Why?
|
| Transfection | 2 | 2007 | 1075 | 0.060 |
Why?
|
| Genetic Code | 1 | 2005 | 40 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 697 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2006 | 391 | 0.060 |
Why?
|
| Genome, Insect | 1 | 2006 | 97 | 0.060 |
Why?
|
| Species Specificity | 1 | 2006 | 551 | 0.060 |
Why?
|
| Molecular Targeted Therapy | 2 | 2021 | 373 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2006 | 160 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 2412 | 0.060 |
Why?
|
| Aged | 2 | 2020 | 19900 | 0.060 |
Why?
|
| RNA, Double-Stranded | 2 | 2021 | 63 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 319 | 0.060 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2004 | 5 | 0.060 |
Why?
|
| Brain | 2 | 2014 | 3008 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 1333 | 0.060 |
Why?
|
| I-kappa B Kinase | 1 | 2004 | 61 | 0.060 |
Why?
|
| Chromatin | 1 | 2007 | 568 | 0.060 |
Why?
|
| Untranslated Regions | 1 | 2003 | 8 | 0.060 |
Why?
|
| Base Composition | 1 | 2003 | 71 | 0.050 |
Why?
|
| Cell Line | 2 | 2007 | 2760 | 0.050 |
Why?
|
| Cytosine | 1 | 2003 | 57 | 0.050 |
Why?
|
| Guanine | 1 | 2003 | 61 | 0.050 |
Why?
|
| Genes | 1 | 2004 | 447 | 0.050 |
Why?
|
| Mammals | 1 | 2004 | 258 | 0.050 |
Why?
|
| Melanoma | 1 | 2009 | 944 | 0.050 |
Why?
|
| Receptors, Notch | 2 | 2016 | 205 | 0.050 |
Why?
|
| RNA | 1 | 2005 | 575 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 1590 | 0.050 |
Why?
|
| Lung | 1 | 2009 | 1496 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1700 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2003 | 475 | 0.050 |
Why?
|
| Software | 1 | 2005 | 686 | 0.040 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 67 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 772 | 0.040 |
Why?
|
| HeLa Cells | 2 | 2015 | 807 | 0.040 |
Why?
|
| Protein Array Analysis | 1 | 2021 | 101 | 0.040 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 76 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 585 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2021 | 89 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2021 | 184 | 0.040 |
Why?
|
| Endocytosis | 1 | 2020 | 125 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 37 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 296 | 0.040 |
Why?
|
| Uridine Diphosphate Glucuronic Acid | 1 | 2019 | 6 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 200 | 0.040 |
Why?
|
| Estrogen Antagonists | 1 | 2020 | 104 | 0.040 |
Why?
|
| Chorioallantoic Membrane | 1 | 2019 | 12 | 0.040 |
Why?
|
| Chick Embryo | 1 | 2019 | 131 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 138 | 0.040 |
Why?
|
| ras Proteins | 1 | 2020 | 139 | 0.040 |
Why?
|
| PPAR gamma | 1 | 2019 | 88 | 0.040 |
Why?
|
| Triterpenes | 1 | 2018 | 21 | 0.040 |
Why?
|
| Phospholipase C beta | 1 | 2018 | 7 | 0.040 |
Why?
|
| Phospholipid Ethers | 1 | 2018 | 8 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 41 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2004 | 3061 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 19 | 0.040 |
Why?
|
| Estradiol | 1 | 2020 | 532 | 0.040 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2018 | 22 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 34 | 0.040 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 43 | 0.040 |
Why?
|
| Estrogens | 1 | 2020 | 505 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2019 | 238 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2017 | 32 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2018 | 63 | 0.040 |
Why?
|
| Breast | 1 | 2019 | 213 | 0.040 |
Why?
|
| Purines | 1 | 2018 | 116 | 0.040 |
Why?
|
| Ribosomes | 1 | 2018 | 137 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 2651 | 0.040 |
Why?
|
| Glycolysis | 1 | 2018 | 151 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 679 | 0.030 |
Why?
|
| Proteomics | 1 | 2021 | 508 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2021 | 1520 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 171 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2017 | 245 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 453 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2011 | 794 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 735 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2017 | 340 | 0.030 |
Why?
|
| Splicing Factor U2AF | 1 | 2015 | 11 | 0.030 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2015 | 10 | 0.030 |
Why?
|
| Phenotype | 1 | 2005 | 4273 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 604 | 0.030 |
Why?
|
| Wnt1 Protein | 1 | 2015 | 71 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2015 | 49 | 0.030 |
Why?
|
| RNA Splicing Factors | 1 | 2015 | 50 | 0.030 |
Why?
|
| Ribonucleoproteins | 1 | 2015 | 64 | 0.030 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2015 | 14 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 100 | 0.030 |
Why?
|
| Quinazolines | 1 | 2015 | 175 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 1026 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 176 | 0.030 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2014 | 6 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 320 | 0.030 |
Why?
|
| Plasminogen Activators | 1 | 2014 | 20 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2014 | 34 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 358 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 172 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 420 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2020 | 1912 | 0.030 |
Why?
|
| Retroviridae | 1 | 2013 | 198 | 0.030 |
Why?
|
| Male | 4 | 2020 | 61776 | 0.030 |
Why?
|
| Interleukin-11 | 1 | 2012 | 7 | 0.030 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2012 | 13 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2012 | 44 | 0.030 |
Why?
|
| Goosecoid Protein | 1 | 2011 | 4 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2012 | 108 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 30 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2016 | 909 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3095 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 554 | 0.020 |
Why?
|
| Astrocytes | 1 | 2014 | 251 | 0.020 |
Why?
|
| Survival Rate | 1 | 2016 | 2073 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2011 | 87 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 357 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 344 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 220 | 0.020 |
Why?
|
| Algorithms | 1 | 2017 | 1632 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 2178 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 659 | 0.020 |
Why?
|
| Leukocytes | 1 | 2011 | 212 | 0.020 |
Why?
|
| Cytoskeletal Proteins | 1 | 2011 | 271 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2568 | 0.020 |
Why?
|
| Sialyltransferases | 1 | 2009 | 6 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2009 | 17 | 0.020 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 1 | 2009 | 14 | 0.020 |
Why?
|
| Recurrence | 1 | 2012 | 1420 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 296 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 155 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 973 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2011 | 1082 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 428 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 143 | 0.020 |
Why?
|
| Angiopoietins | 1 | 2008 | 21 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2008 | 25 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2008 | 71 | 0.020 |
Why?
|
| Macaca | 1 | 2008 | 61 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2011 | 2714 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2008 | 216 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2007 | 212 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2006 | 22 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 282 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 667 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 676 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3597 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2011 | 1041 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1410 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 772 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 862 | 0.010 |
Why?
|
| Genome, Human | 1 | 2007 | 1284 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2006 | 715 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 16417 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12420 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 27000 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 29734 | 0.010 |
Why?
|